CCNG2 Polyclonal Antibody

The eukaryotic cell cycle is governed by cyclin-dependent protein kinases (CDKs) whose activities are regulated by cyclins and CDK inhibitors. The 8 species of cyclins reported in mammals, cyclins A through H, share a conserved amino acid sequence of about 90 residues called the cyclin box. The amino acid sequence of cyclin G is well conserved among mammals. The nucleotide sequence of cyclin G1 and cyclin G2 are 53% identical. Unlike cyclin G1, cyclin G2 contains a C-terminal PEST protein destabilization motif, suggesting that cyclin G2 expression is tightly regulated through the cell cycle.

The CCNG2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CCNG2 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity.

The CCNG2 Polyclonal Antibody exhibits exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes endogenous levels of CCNG2 protein, making it an ideal choice for studying the regulation and function of CCNG2 in different cellular contexts.

With its superior specificity and minimal cross-reactivity, this antibody guarantees accurate and reproducible results. It has been extensively validated in multiple experimental settings, demonstrating its reliability and consistency. The CCNG2 Polyclonal Antibody is manufactured under strict quality control standards, ensuring batch-to-batch consistency and long-term stability.

In summary, the CCNG2 Polyclonal Antibody is a valuable research tool for scientists investigating the role of CCNG2 in various biological processes. Its exceptional performance, reliability, and specificity make it an indispensable asset for any laboratory conducting studies related to CCNG2 protein expression and function.